致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Biotinylated Human LILRB3/CD85a/ILT5, Avi-His-tag
目录号 NBL-242341
别名 LILRB3/CD85a/ILT5; CD85a; ILT5; ILT-5; LILRB3; LIR3; LIR3CD85A; LIR-3MGC138403; PIRB; HL9
外观 see COA
分子量
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 O75022-1
备注2
目录号 规格 价格 库存状态  
NBL-242341-100ug 100ug Inquire Inquire
NBL-242341-1mg 1mg Inquire Inquire
NBL-242341-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Biotinylated Human LILRB3/CD85a/ILT5, Avi-His-tag


Catalog#:

NBL-242341


Description:

NebuSelect™ Recombinant Biotinylated Human LILRB3/CD85a/ILT5, Avi-His-tag(Cat#NBL-242341) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly24-Glu443.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 50 kDa. Due to glycosylation, the protein migrates to 60-72 kDa based on Bis-Tris PAGE result.


Target Name:

LILRB3/CD85a/ILT5; CD85a; ILT5; ILT-5; LILRB3; LIR3; LIR3CD85A; LIR-3MGC138403; PIRB; HL9


Target Information:

Leukocyte immunoglobulin-like receptor subfamily B (LILRB3), also known as ILT5, LIR3, and CD85a, is an immunoglobulin superfamily member that is involved in immune regulation. Subfamily B members have cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that inhibit signaling events via phosphatase SHP-1.LILRB3 may act as receptor for class I MHC antigens. Becomes activated upon coligation of LILRB3 and immune receptors, such as FCGR2B and the B-cell receptor.


Amino Acid Sequence: 


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品